MaxCyte Current Assets

MaxCyte (MXCT) currently reports a current assets of $2.1B as of September 2026. That compares with $120M in the prior-year period — up 1596.7% year over year. Use the charts on this page to explore MaxCyte's current assets history and peer comparisons.

MaxCyte's current assets increased from $120M to $2.1B — a 1596.7% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

MaxCyte reported $2.1B in current assets as of September 2026. That compares with $120M in the prior-year period — up 1596.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $2.1B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for MaxCyte, and consider following MXCT for alerts when major investors trade the stock.

MaxCyte is classified in the Materials sector. On current assets, it currently shows $2.1B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Materials are usually more informative than comparing MXCT with unrelated industries.